European shares ended lower on Monday as surging COVID-19 cases raised the possibility of further economic restrictions, outweighing optimism from signs of progress on a Brexit trade deal and hopes of fiscal stimulus in the United States.
European stocks posted a second consecutive week of gains on Friday as bumper forecasts from Denmark's Pandora and Novo Nordisk set a brighter tone for the earnings season, while investors kept an eye out for signs of fresh U.S. stimulus.
European stocks hit a near three-week high on Thursday as investors globally pinned hopes on more U.S. stimulus even as coronavirus cases surged across the continent.
European stocks mostly fell on Wednesday, failing to join a recovery in global equities following a selloff on doubts over U.S. stimulus, with blue-chip shares weighing the most.
European stocks stretched their gains for a fourth session on Tuesday, with banks surging more than 3% over growing hopes for a U.S. stimulus package, a Brexit trade deal as well as upbeat German data.
European shares closed at a two-week high on Monday, as positive updates on U.S. President Donald Trump's health, a U.S. stimulus package and a spate of dealmaking activity lifted investor spirits.
European stocks closed slightly higher on Friday, shaking off early weakness sparked by news that U.S. President Donald Trump tested positive for COVID-19 as investors pinned hopes on more stimulus.